PTPN14 mutations have been identified in a variety of human malignancies, including breast cancer, colon cancer, and skin basal cell carcinoma [25–27], and thus PTPN14 has been implicated as a putative tumor and metastasis suppressor. Here, PTPN14 is linked to breast carcinoma.